Home › Trial NCT04771897
A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)
- Trial IDNCT04771897
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorBexion Pharmaceuticals, Inc.
- Enrollment10
- Start date2021-05-24
- ConditionsDiffuse Intrinsic Pontine Glioma · Diffuse Midline Glioma, H3 K27M-Mutant
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.